Recently, GYENNO, a precision medical service provider based on rehabilitation robots, has received tens of millions of A rounds of financing. This round of financing was led by the Jordan Medical Fund and the Wuhan Optics Valley Talent Fund.
Founded in 2013, GYENNO was originally engaged in the research and development of smart bracelets. Since 2014, the company has focused on the Parkinson field, providing systematic solutions to functional disorders for Parkinson's and motor dysfunction patients.
It is understood that with the global aging, the number of patients with Parkinson's disease is high. The number of patients with Parkinson's disease in China is about 4 million. The prevalence rate of elderly people over 65 years old is 1.7%, and it is younger. Parkinson's disease is the third most serious affecting the health of middle-aged and old people after cancer and cardiovascular disease. Major diseases. Because the pathogenesis of Parkinson is not clear at present, traditional methods such as drugs and surgery are still very scarce, and patients cannot be cured once they are sick. Therefore, solving the functional disorders of Parkinson's patients through medical rehabilitation robots and improving the quality of life of patients become an important development trend of medical care in the future.
At present, GYENNO has launched the GYENNO Smart Meal Spoon and the Chronic Disease Management System Medical Power App, which are specially designed for Parkinson's and dyskinesia patients, to form a closed-loop telemedicine solution including assist, detection and intervention. GYENNO Rui meal is a small robot with two sets of motor control system. It captures the patient's hand dynamics through sensors, and uses the high-speed servo control system to actively correct the position of the spoon surface for different hand movements, thus assisting the patient to eat normally. Perform hand balance training to delay the deterioration of hand movement function.
At the same time, the combination of Rui meal and medical power APP can facilitate doctors to detect patients' daily disease data and long-term development trend. In the follow-up, GYENNO will also add video functions to the medical power to realize quick communication between doctors and patients. In addition, through the record and data analysis of the patient's disease data and medication, it can also form an objective reference for the medication strategy, assist the doctor to assess the development of the disease and the drug effect, achieve accurate medication, and help prolong the honeymoon period of the drug.
In the first half of 2016, GYENNO Rui meal has been officially mass-produced and sold to more than 10 countries including China, the United States and the United Kingdom. Currently, the sales volume is several thousand.
In fact, Google's Liftware team has previously launched similar smart meal spoons for patients with Parkinson's disease and hand disorders caused by polio, stroke, etc. - Liftware Steady and Liftware Level. GYENNO founder Ren Kang said that compared with this, GYENNO's starting point is to extend vertically in the Parkinson's rehabilitation field, and Liftware is laterally expanding in the direction of hand obstacles. In terms of product functionality, GYENNO Rui meal can offset 85% of hand shake in the vertical direction, and offset about 65% of the jitter in the horizontal direction, which is better than the Liftware Steady anti-shake level. At the same time, it also added data analysis function to assist doctors to follow up.
medical Angio Closure Pad,angio syringe,Angio Closure Pad
Anesthesia Medical Co., Ltd. , https://www.jssinoanesthesia.com